16
Participants
Start Date
April 30, 2008
Primary Completion Date
February 28, 2010
Study Completion Date
February 28, 2010
Irinotecan
Irinotecan (IV) 150 mg/m2 on day 1 every two weeks until progression
Avastin
Avastin (IV) 10 mgr/Kgr on day 1 every 2 weeks until progression
Erbitux
Erbitux (IV)500 mg/m2 on day 1 every two weeks until progression
University General Hospital of Alexandroupolis, Dep of Medical Oncology, Alexandroupoli
401 Military Hospital of Athens, Athens
": Laikon General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine", Athens
Air Forces Military Hospital of Athens, Athens
"IASO General Hospital of Athens, 1st Dep of Medical Oncology", Athens
State General Hospital of Larissa, Larissa
"Metaxa's Anticancer Hospital of Piraeus, 1st Dep of Medical Oncology", Piraeus
"Theagenion Anticancer Hospital of Thessaloniki, 2nd Dep of Medical Oncology", Thessaloniki
Lead Sponsor
University Hospital of Crete
OTHER
Hellenic Oncology Research Group
OTHER